NASDAQ:ABSI Absci (ABSI) Stock Price, News & Analysis → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Free ABSI Stock Alerts $5.68 +0.14 (+2.53%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$5.51▼$5.7650-Day Range$3.41▼$5.7452-Week Range$1.11▼$6.40Volume1.20 million shsAverage Volume1.57 million shsMarket Capitalization$640.65 millionP/E RatioN/ADividend YieldN/APrice Target$9.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Absci alerts: Email Address Absci MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside63.7% Upside$9.25 Price TargetShort InterestBearish13.25% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.09Based on 18 Articles This WeekInsider TradingAcquiring Shares$999,999 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.77) to ($0.65) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.91 out of 5 starsMedical Sector632nd out of 939 stocksCommercial Physical Research Industry9th out of 10 stocks 3.5 Analyst's Opinion Consensus RatingAbsci has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.25, Absci has a forecasted upside of 63.7% from its current price of $5.65.Amount of Analyst CoverageAbsci has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted13.25% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Absci has recently increased by 0.56%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAbsci does not currently pay a dividend.Dividend GrowthAbsci does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ABSI. Previous Next 1.6 News and Social Media Coverage News SentimentAbsci has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Absci this week, compared to 1 article on an average week.Search InterestOnly 20 people have searched for ABSI on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat Follows28 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 180% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Absci insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,999.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.58% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Absci are expected to grow in the coming year, from ($0.77) to ($0.65) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Absci is -4.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Absci is -4.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAbsci has a P/B Ratio of 2.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyAI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. About Absci Stock (NASDAQ:ABSI)Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.Read More ABSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABSI Stock News HeadlinesMarch 27, 2024 | americanbankingnews.comAbsci's (ABSI) Buy Rating Reaffirmed at Truist FinancialMarch 26, 2024 | americanbankingnews.comAbsci's (ABSI) "Outperform" Rating Reaffirmed at ScotiabankMarch 28, 2024 | Porter & Company (Ad)AI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… March 23, 2024 | finance.yahoo.comAbsci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net LossMarch 23, 2024 | americanbankingnews.comAbsci's (ABSI) "Buy" Rating Reiterated at HC WainwrightMarch 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for AbSci: Promising Pipeline and Strategic Partnerships Signal GrowthMarch 21, 2024 | benzinga.comAbsci: Q4 Earnings InsightsMarch 21, 2024 | investorplace.comABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023March 28, 2024 | Porter & Company (Ad)AI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… March 21, 2024 | globenewswire.comAbsci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsMarch 13, 2024 | finance.yahoo.comABSI Apr 2024 6.000 callMarch 7, 2024 | investing.comAbsci shares get buy rating, $9 target on AI biotech potentialMarch 1, 2024 | finance.yahoo.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesMarch 1, 2024 | globenewswire.comAbsci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional SharesFebruary 28, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on AbSci (ABSI)February 28, 2024 | msn.comWhy Absci (ABSI) Shares Are FallingFebruary 28, 2024 | msn.comAbsci prices $75M equity offering at $4.50 per shareFebruary 27, 2024 | globenewswire.comAbsci Announces Pricing of Public Offering of Common StockFebruary 27, 2024 | globenewswire.comAbsci Announces Proposed Public Offering of Common StockFebruary 24, 2024 | ca.finance.yahoo.comCNC Mar 2024 86.000 callFebruary 21, 2024 | finance.yahoo.comIs Centene (CNC) Stock Outpacing Its Medical Peers This Year?February 21, 2024 | finance.yahoo.comAbsci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AIFebruary 21, 2024 | globenewswire.comAbsci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AIFebruary 16, 2024 | finance.yahoo.comABSI Mar 2024 7.500 callFebruary 16, 2024 | finance.yahoo.comABSI Feb 2024 7.500 putFebruary 5, 2024 | finance.yahoo.comIs Absci Corporation (ABSI) Outperforming Other Medical Stocks This Year?January 21, 2024 | finance.yahoo.comBoth retail investors who control a good portion of Absci Corporation (NASDAQ:ABSI) along with institutions must be dismayed after last week's 15% decreaseSee More Headlines Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today3/28/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ABSI CUSIPN/A CIK1672688 Webwww.absci.com Phone360-949-1041FaxN/AEmployees193Year FoundedN/APrice Target and Rating Average Stock Price Target$9.25 High Stock Price Target$13.00 Low Stock Price Target$7.00 Potential Upside/Downside+63.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-110,570,000.00 Net Margins-1,933.65% Pretax Margin-1,931.90% Return on Equity-44.52% Return on Assets-37.35% Debt Debt-to-Equity Ratio0.03 Current Ratio4.08 Quick Ratio4.08 Sales & Book Value Annual Sales$5.72 million Price / Sales111.80 Cash FlowN/A Price / Cash FlowN/A Book Value$1.90 per share Price / Book2.98Miscellaneous Outstanding Shares112,790,000Free Float99,724,000Market Cap$639.52 million OptionableOptionable Beta2.35 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Sean McClain (Age 34)Founder, CEO, President & Director Comp: $936.2kDr. Zachariah Jonasson Ph.D. (Age 50)Chief Business Officer & CFO Comp: $98.3kDr. Andreas Busch Ph.D. (Age 61)Chief Innovation Officer & Member of Scientific Advisory Board Comp: $1.56MMr. Todd Bedrick CPASenior VP & Chief Accounting OfficerMr. Alexander Khan CPAVP of Finance & Head of Investor RelationsMr. Jack GoldChief Marketing OfficerMs. Karin WierinckChief People OfficerMelissa Patterson Ph.D.Chief of StaffJens Plassmeier Ph.D.Senior VP of Biologics Discovery TechnologyMr. Wen ShaChief of StaffMore ExecutivesKey CompetitorsOmniAbNASDAQ:OABIMaxCyteNASDAQ:MXCTHarpoon TherapeuticsNASDAQ:HARPTScan TherapeuticsNASDAQ:TCRXTenaya TherapeuticsNASDAQ:TNYAView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 110,035 shares on 3/11/2024Ownership: 2.772%Redmile Group, LlcBought 222,222 shares on 3/1/2024Total: $999,999.00 ($4.50/share)Vanguard Group Inc.Bought 109,289 shares on 2/15/2024Ownership: 2.771%Bridgeway Capital Management LLCBought 18,500 shares on 2/15/2024Ownership: 0.291%Citadel Advisors LLCSold 7,000 shares on 2/15/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions ABSI Stock Analysis - Frequently Asked Questions Should I buy or sell Absci stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ABSI shares. View ABSI analyst ratings or view top-rated stocks. What is Absci's stock price target for 2024? 4 equities research analysts have issued 1 year target prices for Absci's shares. Their ABSI share price targets range from $7.00 to $13.00. On average, they anticipate the company's stock price to reach $9.25 in the next twelve months. This suggests a possible upside of 63.7% from the stock's current price. View analysts price targets for ABSI or view top-rated stocks among Wall Street analysts. How have ABSI shares performed in 2024? Absci's stock was trading at $4.20 at the beginning of the year. Since then, ABSI stock has increased by 34.5% and is now trading at $5.65. View the best growth stocks for 2024 here. When is Absci's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our ABSI earnings forecast. How were Absci's earnings last quarter? Absci Co. (NASDAQ:ABSI) announced its quarterly earnings results on Thursday, March, 21st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.02. The business had revenue of $0.34 million for the quarter, compared to analysts' expectations of $1.75 million. Absci had a negative trailing twelve-month return on equity of 44.52% and a negative net margin of 1,933.65%. When did Absci IPO? Absci (ABSI) raised $200 million in an initial public offering (IPO) on Thursday, July 22nd 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. Who are Absci's major shareholders? Absci's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.77%), Vanguard Group Inc. (2.77%), Platinum Investment Management Ltd. (0.90%), Hsbc Holdings PLC (0.44%), Charles Schwab Investment Management Inc. (0.38%) and Bridgeway Capital Management LLC (0.29%). Insiders that own company stock include Karen K Mcginnis, Redmile Group, Llc, Sarah Korman, Sean Mcclain and Todd Bedrick. View institutional ownership trends. How do I buy shares of Absci? Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ABSI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.